Abridge
About Abridge
Abridge is a healthcare technology startup that focuses on improving patient-provider communication through innovative solutions. The platform helps patients capture and understand their medical conversations, ensuring they have access to critical health information.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Round | Date | Amount | Investors |
---|---|---|---|
Series E | Jun 24, 2025 | $300.0M | a16zcrypto CSX, Andreessen Horowitz (a16z), Khosla Ventures +2 more |
Series D | Feb 01, 2023 | $250.0M | Unknown |
Founders
No founder information available.
Investors
Andreessen Horowitz (a16z)
Venture Capital
Khosla Ventures
Venture Capital
WndrCo
Venture Capital
a16zcrypto CSX
Venture Capital
khoslaventures
Venture Capital
Recent Mentions
@vchennai2 Check out Abridge. Pittsburgh, PA. Valuation: $2.75 billion & just had a $250 million Series D round in Feb. "Only real place" is a wonderful tale people tell themselves, but not true if we follow facts. SF is a great - but great people & companies are everywhere.
.@TechCrunch In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B: Abridge nabbed $300 million Series E led by a16z, months after it closed its previous $250M fundraise. https://t.co/qIYh2m0SUX #tech #startups #VC https://t.co/pEJLtK27bP
AI scribe developer Abridge raised $300 million in a Series E funding round led by Andreessen Horowitz. https://t.co/gMa0zw3II6
NEW: Abridge raised $300M Series E led by a16z and Khosla at a $5.3B valuation—doubling since its $250M raise in Feb. Now used in 150 health systems, Abridge will support 50M+ medical conversations this year and aims to cut clinician burnout by up to 70%. https://t.co/3c5tCjon8f
Abridge raises $300M Series E funding round led by @a16z, and joined by @khoslaventures to pioneer a new paradigm of care with intelligence at the point of conversation. 🚀 @DavidGeorge83, 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗮𝘁 𝗔𝗻𝗱𝗿𝗲𝗲𝘀𝘀𝗲𝗻 𝗛𝗼𝗿𝗼𝘄𝗶𝘁𝘇: “Abridge https://t.co/Rk4eXZZULi
🇺🇸 New Deal: WndrCo has invested in Abridge's $300 million Series E funding round, aiming to enhance healthcare documentation through innovative AI technol... #Mergers & #Acquisitions #mergersandacquisitions #PrivateEquity #Dealert 🔗 Link: https://t.co/XypNFzvgVE
Nabla’s $70M round appeared in this chart showing that $900M has been invested in seven AI scribe startups across ten funding rounds over the past two years. Then came Abridge’s $300M Series E last week—pushing the total to $1.2B across 11 rounds. https://t.co/8mIFwoxF7c
Similar Startups
AbridgeHQ
95% matchBringing intelligence to the point of conversation and transforming healthcare.
CureBay
87% matchA hybrid healthcare platform focused on delivering last-mile medical services.
cure_bay
87% matchCureBay is a tech-first hybrid healthcare platform focused on providing accessible healthcare soluti...
Skriber
87% matchA medical AI scribe company dedicated to freeing healthcare providers from administrative burden.